Comparison of the therapeutic efficacy and ovarian reserve between catheter-directed sclerotherapy and surgical excision for ovarian endometrioma

article OA: green CC0 ⤵ 19 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-14 ⓘ

Catheter-directed sclerotherapy (CDS) demonstrated comparable symptom relief and preserved ovarian reserve with a shorter hospital stay than surgical excision for ovarian endometriomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

This retrospective observational study compared catheter-directed sclerotherapy (CDS) using 99% ethanol with surgical excision in 71 patients with symptomatic ovarian endometriomas, assessing symptom relief, CA-125, recurrence-related clinical outcomes, complications, hospitalization length, and ovarian reserve via serial serum anti-Müllerian hormone (AMH). The authors found no significant difference in symptom relief between CDS and surgery over a mean follow-up of 22.3 months, while hospitalization was shorter with CDS; CA-125 decreased in both groups. Serum AMH remained stable after CDS but significantly decreased after surgical excision, and minor complications occurred only in the surgery group. Limitations include its retrospective, single-institution design and a follow-up window that varied widely, with some CDS patients previously reported in a single-arm study. This paper is centrally about endometriosis — specifically comparing CDS versus surgical excision outcomes for ovarian endometrioma, including effects on ovarian reserve.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

ObjectivesTo compare the efficacies of catheter-directed sclerotherapy (CDS) with 99% ethanol and surgery for ovarian endometrioma and their impact on the ovarian reserve.MethodsFrom January 2011 to June 2019, 71 patients who underwent surgical excision (n = 51) or CDS (n = 20) for symptomatic ovarian endometriomas were reviewed. To analyze the effect on the ovarian reserve, serum anti-Müllerian hormone (AMH) levels were compared before and after the procedure. Symptoms, serum cancer antigen 125 (CA-125), lesion size, recurrence, hospitalization, and complications were reviewed retrospectively.ResultsDuring a mean follow-up of 22.3 months (range, 6 to 94 months), no significant difference in symptom relief was found between CDS and surgery (95.0% [19/20] and 92.2% [47/51], respectively, p > 0.999). The hospital stay was shorter with CDS than with surgery (2.6 ± 0.6 days and 4.1 ± 0.5 days, respectively, p < 0.001). There was no significant difference in serum AMH levels before and after CDS (2.3 (interquartile range (IQR) 1.1-5.3) ng/mL and 2.6 (IQR 0.9-4.9) ng/mL, respectively, p = 0.243), but there was a significant decrease in serum AMH in the surgery group (3.0 (IQR 1.3-5.5) ng/mL and 1.6 (IQR 0.7-3.2) ng/mL, respectively, p < 0.001). CA-125 decreased in both CDS and surgery groups (p = 0.001 and < 0.001, respectively). Two minor complications occurred in the surgery group, while no complication was observed in the CDS group.ConclusionsThe therapeutic efficacy of CDS appears to be comparable to that of surgical resection for ovarian endometrioma. Ovarian function was well-preserved, and a shorter hospital stay was required in patients who underwent CDS.Key points• There was no significant difference in symptom relief between CDS and surgery (95.0% [19/20], 92.2% [47/51], respectively, p >0.999). • No significant difference in serum AMH levels was seen before and after CDS (2.3 (1.1, 5.3)* ng/mL, 2.6 (0.9, 4.9)* ng/mL, respectively, p = 0.243), whereas serum AMH levels significantly decreased after surgical resection (3.0 (1.3, 5.5)* ng/mL, 1.6 (0.7, 3.2)* ng/mL, respectively, p <0.001). *Median (25 quartiles, 75 quartiles) • The hospitalization period was shorter with CDS than with surgery (2.6 ± 0.6 days, 4.1 ± 0.5 days, respectively, p <0.001).
Full text 7,296 characters · extracted from oa-html · 5 sections · click to expand

Abstract

Objectives To compare the efficacies of catheter-directed sclerotherapy (CDS) with 99% ethanol and surgery for ovarian endometrioma and their impact on the ovarian reserve.

Methods

From January 2011 to June 2019, 71 patients who underwent surgical excision (n = 51) or CDS (n = 20) for symptomatic ovarian endometriomas were reviewed. To analyze the effect on the ovarian reserve, serum anti-Müllerian hormone (AMH) levels were compared before and after the procedure. Symptoms, serum cancer antigen 125 (CA-125), lesion size, recurrence, hospitalization, and complications were reviewed retrospectively.

Results

During a mean follow-up of 22.3 months (range, 6 to 94 months), no significant difference in symptom relief was found between CDS and surgery (95.0% [19/20] and 92.2% [47/51], respectively, p > 0.999). The hospital stay was shorter with CDS than with surgery (2.6 ± 0.6 days and 4.1 ± 0.5 days, respectively, p < 0.001). There was no significant difference in serum AMH levels before and after CDS (2.3 (interquartile range (IQR) 1.1–5.3) ng/mL and 2.6 (IQR 0.9–4.9) ng/mL, respectively, p = 0.243), but there was a significant decrease in serum AMH in the surgery group (3.0 (IQR 1.3–5.5) ng/mL and 1.6 (IQR 0.7–3.2) ng/mL, respectively, p < 0.001). CA-125 decreased in both CDS and surgery groups (p = 0.001 and < 0.001, respectively). Two minor complications occurred in the surgery group, while no complication was observed in the CDS group.

Conclusions

The therapeutic efficacy of CDS appears to be comparable to that of surgical resection for ovarian endometrioma. Ovarian function was well-preserved, and a shorter hospital stay was required in patients who underwent CDS. Key Points • There was no significant difference in symptom relief between CDS and surgery (95.0% [19/20], 92.2% [47/51], respectively, p >0.999). • No significant difference in serum AMH levels was seen before and after CDS (2.3 (1.1, 5.3)* ng/mL, 2.6 (0.9, 4.9)* ng/mL, respectively, p = 0.243), whereas serum AMH levels significantly decreased after surgical resection (3.0 (1.3, 5.5)* ng/mL, 1.6 (0.7, 3.2)* ng/mL, respectively, p <0.001). *Median (25 quartiles, 75 quartiles) • The hospitalization period was shorter with CDS than with surgery (2.6 ± 0.6 days, 4.1 ± 0.5 days, respectively, p <0.001). Similar content being viewed by others Abbreviations - AMH: - Anti-Müllerian hormone - CDS: - Catheter-directed sclerotherapy - NDS: - Needle-directed sclerotherapy - CA-125: - Serum cancer antigen 125

References

Giudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362:2389–2398 Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258 Vercellini P, Vigano P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10:261–275 Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB (2002) Management of ovarian endometriomas. Hum Reprod Update 8:591–597 Cohen A, Almog B, Tulandi T (2017) Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril 108:117–124.e115 Busacca M, Riparini J, Somigliana E et al (2006) Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 195:421–425 Raffi F, Metwally M, Amer S (2012) The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:3146–3154 Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L (2012) Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antiMüllerian hormone level modifications. Fertil Steril 98:1531–1538 Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T (1988) Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol. Nihon Sanka Fujinka Gakkai Zasshi 40:187–191 Han K, Seo SK, Kim MD et al (2018) Catheter-directed sclerotherapy for ovarian endometrioma: short-term outcomes. Radiology 289:854–859 Hsieh CL, Shiau CS, Lo LM, Hsieh TT, Chang MY (2009) Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril 91:2709–2713 Noma J, Yoshida N (2001) Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet 72:35–39 Wang SM, Cai HQ, Dong XQ et al (2015) Correlation between ovarian chocolate cyst and serum carbohydrate antigen 125 level and the effect of ultrasound-guided interventional sclerotherapy on serum carbohydrate antigen 125 level. J Obstet Gynaecol Res 41:92–98 Aflatoonian A, Rahmani E, Rahsepar M (2013) Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: a randomized clinical trial. Iran J Reprod Med 11:179–184 Gatta G, Parlato V, Di Grezia G et al (2010) Ultrasound-guided aspiration and ethanol sclerotherapy for treating endometrial cysts. Radiol Med 115:1330–1339 Ikuta A, Tanaka Y, Mizokami T et al (2006) Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts. J Med Ultrason (2001) 33:99–103 Albanese G, Kondo KL (2010) Pharmacology of sclerotherapy. Semin Interv Radiol 27:391–399 Celik HG, Dogan E, Okyay E et al (2012) Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antiMüllerian hormone levels. Fertil Steril 97:1472–1478 Lee KH, Kim CH, Lee YJ, Kim SH, Chae HD, Kang BM (2014) Surgical resection or aspiration with ethanol sclerotherapy of endometrioma before in vitro fertilization in infertile women with endometrioma. Obstet Gynecol Sci 57:297–303 Funding This study was supported by a faculty research grant of Yonsei University College of Medicine (6-2020-0007). Author information Authors and Affiliations Corresponding authors Ethics declarations Guarantor The scientific guarantor of this publication is Kichang Han. Conflict of interest The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry No complex statistical methods were necessary for this paper. Informed consent Written informed consent was waived by the Institutional Review Board. Ethical approval Institutional Review Board approval was obtained. Study subjects or cohorts overlap Fourteen of the 20 patients who had undergone CDS have been previously reported [13]. The prior study was a single-arm study lacking a control group, whereas in this manuscript, we compared CDS with surgical resection. Methodology • Retrospective • Observational • Performed at one institution Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions About this article Cite this article Koo, J.H., Lee, I., Han, K. et al. Comparison of the therapeutic efficacy and ovarian reserve between catheter-directed sclerotherapy and surgical excision for ovarian endometrioma. Eur Radiol 31, 543–548 (2021). https://doi.org/10.1007/s00330-020-07111-1 Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00330-020-07111-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

MeSH descriptors

Endometriosis Endometriosis Laparoscopy Ovarian Reserve Catheters Female Humans Ovary Ovary Retrospective Studies Sclerotherapy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (20)

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:47.975235+00:00
License: CC0 · commercial use OK